Clinical research products development center (CRPMC)

Active Definitive Contract Awarded Last action

Contract number
75N93020C00032
Awardee
Awarding agency
Obligated
$62,984,999

Award facts

Opportunity
Contract value 74% obligated
  • $62,984,999.47 Current, with exercised options
  • $85,307,552.47 Potential, with all options
Completion date 91% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Rockville, MD 20850, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00017 -$597,281
Funding Only Action P00016 · EO14398; clinical research products development center (CRPMC) -$529,462
Exercise an Option P00015 $8,891,425
Funding Only Action P00014 -$400,772
Exercise an Option P00013 $8,628,931
Exercise an Option P00012 $8,406,422
Exercise an Option P00011 $735,708
Exercise an Option P00010 $9,069,700
Exercise an Option P00009 · Exercise option 9 (quantity option) to support monkey POX related work. Clinical research products development center (CRPMC) $717,444
Exercise an Option P00008 · Covid 19 related work under option 37 - clinical research products development center (CRPMC) $8,537,828
Other Administrative Action P00007 $0
Exercise an Option P00006 · Covid -19 clinical research products development center (CRPMC) $699,637
Other Administrative Action P00005 $0
Exercise an Option P00004 $9,542,654
Exercise an Option P00003 · Covid-19 related work - clinical research products development center (CRPMC) $514,470
Other Administrative Action P00002 $0
Exercise an Option P00001 · Covid-19 related work - clinical research products development center (CRPMC) $1,196,744
Original award $7,571,551
Show all 18

About this award

The National Institute of Allergy and Infectious Diseases awarded a definitive contract to Fisher Bioservices Inc., Clinical Trials Division, for pharmaceutical services and study product management supporting the Clinical Research Products Management Center on June 16, 2020, with a $85.3 million ceiling and an ultimate completion date of June 15, 2027.

The originating solicitation (posted July 25, 2018) requested cGMP-compliant receipt, storage, labeling, packaging, distribution, and disposition of investigational products in support of over 80 HIV/AIDS and related clinical trials annually conducted at more than 300 sites in 28 countries. The contract employs cost-plus-fixed-fee pricing. Place of performance is Rockville, MD.

The base period runs one year with six one-year options. NAICS 541715 and PSC D399 apply. The contract was anticipated to deliver 27 full-time equivalents annually with provision for additional optional staffing.

Service Contract Inventory reporting reflects a ramp from $30 thousand in FY2021 (0.4 FTEs, 786 contractor hours) to a stabilized footprint of $7.7–$8.6 million per year across FY2022–FY2025, with 16.2–20.4 FTEs and 37,000–42,500 contractor hours annually. Derived government-paid blended rates rose from $38.21/hr in FY2021 to a peak of $230.04/hr in FY2023, settling near $199/hr by FY2024. Fisher Bioservices self-performed all reported work; no subcontractors appear in SCI reporting.

Quick answers

Who was awarded contract 75N93020C00032?

75N93020C00032 was awarded to Fisher Bioservices Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 16, 2020.

How much is contract 75N93020C00032 worth?

The government has obligated $62,984,999 on 75N93020C00032. Its potential value, with all options, is $85,307,552.

Was contract 75N93020C00032 competed?

The extent of competition for 75N93020C00032 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award